• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
    • Sports
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • Trump Administration
  • IN FOCUS
  • Opinion
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pfizer

    Tag: Pfizer

    AstraZeneca board rejects sweetened takeover offer from Pfizer
    Business

    AstraZeneca board rejects sweetened takeover offer from Pfizer

    Washington Examiner -
    May 2, 2014 9:56 am
    0
    Pfizer still pursuing AstraZeneca after 2nd rebuff
    Business

    Pfizer still pursuing AstraZeneca after 2nd rebuff

    DANICA KIRKALINDA A. JOHNSON -
    April 28, 2014 6:59 pm
    0
    AstraZeneca shares soar on Pfizer interest
    Business

    AstraZeneca shares soar on Pfizer interest

    Danica Kirka -
    April 28, 2014 11:16 am
    0
    Pfizer Inc. proposed buying AstraZeneca Plc for about 58.8 billion pounds ($98.7 billion) in what would rank as the biggest-ever takeover of a U.K. company and continues to be interested in a deal after being spurned. (AP image)
    Healthcare

    Pfizer still wants AstraZeneca after $98.7 billion bid rejected

    oliver-staley, phil-serafino -
    April 28, 2014 4:00 am
    0
    Pfizer to help investors with dividend, buybacks
    Business

    Pfizer to help investors with dividend, buybacks

    The Associated Press -
    April 24, 2014 9:08 pm
    0
    Under the FDA's expanded access program for investigational products, the agency has worked closely with the Centers for Disease Control and Prevention to make the unapproved MenB vaccine, Bexsero, available as quickly as possible for use on two college campuses. (Thinkstock)
    Healthcare

    FDA official: Agency is committed to timely approval of vaccines

    karen-midthun -
    April 18, 2014 4:00 am
    0
    Pfizer reports promising results for cancer drug
    Healthcare

    Pfizer reports promising results for cancer drug

    Christopher Rugaber -
    April 6, 2014 11:42 pm
    0
    1...333435Page 35 of 35
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter